Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-27
DOI
10.3389/fcimb.2022.807095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bedaquiline-resistant Tuberculosis: Dark Clouds on the Horizon
- (2020) Sönke Andres et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
- (2020) Camus Nimmo et al. EUROPEAN RESPIRATORY JOURNAL
- Two Interacting ATPases Protect Mycobacterium tuberculosis from Glycerol and Nitric Oxide Toxicity
- (2020) Meredith Whitaker et al. JOURNAL OF BACTERIOLOGY
- In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
- (2020) Giulia Degiacomi et al. Frontiers in Microbiology
- Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS
- (2019) Rui Pi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance
- (2019) Hassan Safi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
- (2018) Kathryn Schnippel et al. Lancet Respiratory Medicine
- Mutations of Mycobacterium tuberculosis induced by anti-tuberculosis treatment result in metabolism changes and elevation of ethambutol resistance
- (2018) Lin Sun et al. INFECTION GENETICS AND EVOLUTION
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid emergence ofMycobacterium tuberculosisbedaquiline resistance: lessons to avoid repeating past errors
- (2016) Nicolas Veziris et al. EUROPEAN RESPIRATORY JOURNAL
- Unexpected high prevalence of resistance-associatedRv0678variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
- (2016) Cristina Villellas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
- (2016) Eliza J. R. Peterson et al. Nature Microbiology
- Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates
- (2015) PA Black et al. BMC GENOMICS
- Identification of novel mutations associated with clofazimine resistance inMycobacterium tuberculosis: Table 1.
- (2015) Shuo Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Crystal Structure of the Transcriptional Regulator Rv0678 ofMycobacterium tuberculosis
- (2014) Abhijith Radhakrishnan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Discovery of a glycerol 3-phosphate phosphatase reveals glycerophospholipid polar head recycling in Mycobacterium tuberculosis
- (2013) G. Larrouy-Maumus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Neisseria meningitidis Escape from the Bactericidal Activity of a Monoclonal Antibody Is Mediated by Phase Variation of lgtG and Enhanced by a Mutator Phenotype
- (2008) C. D. Bayliss et al. INFECTION AND IMMUNITY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started